Islet Transplant in Patients With Type I Diabetes

Summary

The primary objective of this study is to demonstrate the safety of allogenic islet transplantation in type 1 diabetic patients performed at the University of Virginia. The purpose is to demonstrate that islet transplantation can be performed safely and reliably achieves better glycemic control than state-of-the-art insulin treatment in management of type 1 diabetic patients with brittle control and a history of severe hypoglycemic episodes with hypoglycemia unawareness.

Timeline

Start

2019-08-01

Primary completion

2021-11-01

Completion

2023-12-01

Drugs

Indications